You are here: Industry Insights > brain tumours

News List

UK trial to assess Sativex for the treatment of ‘aggressive’ brain tumours pharmatimes
August 06, 2021
A new UK-based trial is set to assess the efficacy of GW Pharma’s cannabis-based drug Sativex as a potential treatment for patients with a recurrent glioblastoma – the most aggressive form of brain tumours.
Certain brain tumours could respond to immunotherapy pharmaphorum
December 12, 2018
Some brain tumours may respond to immunotherapy after all, according to a new study.So far, brain tumours have been resistant to immunotherapy drugs because.....
Effect of radiation exposure in brain tumours on hormone deficiencies europeanpharmaceuticalreview
August 22, 2018
The study focused on children and young adults receiving proton radiotherapy for brain tumours…
New study discovers faulty genes underlying brain tumours pharmaceutical-technology
July 31, 2017
A new in-depth study funded by Cancer Research UK has shown that medulloblastoma brain tumours have faulty genes underlying the disease.
Celgene hopes device + drug can tackle aggressive brain tumours pharmaphorum
July 27, 2017
Celgene aims to boost the effectiveness of its novel drug marizomib for aggressive brain tumour glioblastoma (GBM) by asking patients to wear a special cap.
Combination therapy shown to shrink tumours in many patients whose cancer has spread to the brain cphi-online
June 06, 2017
Combination of nivolumab plus ipilimumab can fundamentally change survival expectations.
Cancer Research UK funded scientists to test Zika virus on brain tumours pharmaceutical-technology
May 27, 2017
Scientists funded by Cancer Research UK will investigate the effectiveness of the Zika virus in destroying brain tumour cells, which could lead to new treatments for cancer.